×
About 3,308 results

ALLMedicine™ Bullous Pemphigoid Center

Research & Reviews  1,601 results

Inhibition of glucose metabolism abrogates the effector phase of bullous pemphigoid-lik...
https://doi.org/10.1016/j.jid.2021.01.014
The Journal of Investigative Dermatology; Schilf P, Schmitz M et. al.

Feb 20th, 2021 - Bullous pemphigoid-like epidermolysis bullosa acquisita (EBA) is an autoantibody-driven, granulocyte-mediated skin disease. The role of cellular metabolism and its potential as therapeutic target in EBA are unknown. We investigated the effect of 2...

Chronic Systemic Inflammatory Skin Disease as a Risk Factor for Cardiovascular Disease.
https://doi.org/10.1016/j.cpcardiol.2021.100799
Current Problems in Cardiology; Bulger DA, Minhas S et. al.

Feb 19th, 2021 - Chronic systemic skin disease and cardiovascular disease are multisystem disorders which have been associated with each other for centuries. Recent research has strengthened this association, particularly in systemic inflammatory disease. Here we ...

Classifying the severity of bullous pemphigoid disease.
https://doi.org/10.1111/bjd.19830
The British Journal of Dermatology; Blome C, Klein TM

Feb 18th, 2021 - Classifying the severity of bullous pemphigoid disease.|2021|Blome C,Klein TM,|

Clinical characteristics and outcomes of bullous pemphigoid patients with versus withou...
https://doi.org/10.1111/1346-8138.15816
The Journal of Dermatology; Ujiie I, Iwata H et. al.

Feb 18th, 2021 - Bullous pemphigoid (BP) varies in severity and stratified treatments are needed. However, there are no definitive standards for choosing appropriate treatments. To elucidate the factors involved in choosing treatments and the clinical outcomes of ...

The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-yea...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879621
BMC Endocrine Disorders; Lambadiari V, Kountouri A et. al.

Feb 12th, 2021 - Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies have suggested dipeptidyl-peptidase 4 inhibitors as possible predisposing agents of bullous pemphigoid. The objective of our study was to prospectively e...

see more →

Guidelines  2 results

Management of bullous pemphigoid: the European Dermatology Forum consensus in collabora...
https://doi.org/10.1111/bjd.13717
The British Journal of Dermatology; Feliciani C, Joly P et. al.

Apr 1st, 2015 - Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affe...

British Association of Dermatologists' guidelines for the management of bullous pemphig...
https://doi.org/10.1111/bjd.12072
The British Journal of Dermatology; Venning VA, Taghipour K et. al.

Nov 5th, 2012 - British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012.|2012|Venning VA,Taghipour K,Mohd Mustapa MF,Highet AS,Kirtschig G,|therapeutic use,therapeutic use,therapeutic use,therapeutic use,therapeutic use,dia...

see more →

Clinicaltrials.gov  1,631 results

Inhibition of glucose metabolism abrogates the effector phase of bullous pemphigoid-lik...
https://doi.org/10.1016/j.jid.2021.01.014
The Journal of Investigative Dermatology; Schilf P, Schmitz M et. al.

Feb 20th, 2021 - Bullous pemphigoid-like epidermolysis bullosa acquisita (EBA) is an autoantibody-driven, granulocyte-mediated skin disease. The role of cellular metabolism and its potential as therapeutic target in EBA are unknown. We investigated the effect of 2...

Chronic Systemic Inflammatory Skin Disease as a Risk Factor for Cardiovascular Disease.
https://doi.org/10.1016/j.cpcardiol.2021.100799
Current Problems in Cardiology; Bulger DA, Minhas S et. al.

Feb 19th, 2021 - Chronic systemic skin disease and cardiovascular disease are multisystem disorders which have been associated with each other for centuries. Recent research has strengthened this association, particularly in systemic inflammatory disease. Here we ...

Classifying the severity of bullous pemphigoid disease.
https://doi.org/10.1111/bjd.19830
The British Journal of Dermatology; Blome C, Klein TM

Feb 18th, 2021 - Classifying the severity of bullous pemphigoid disease.|2021|Blome C,Klein TM,|

Clinical characteristics and outcomes of bullous pemphigoid patients with versus withou...
https://doi.org/10.1111/1346-8138.15816
The Journal of Dermatology; Ujiie I, Iwata H et. al.

Feb 18th, 2021 - Bullous pemphigoid (BP) varies in severity and stratified treatments are needed. However, there are no definitive standards for choosing appropriate treatments. To elucidate the factors involved in choosing treatments and the clinical outcomes of ...

The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-yea...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879621
BMC Endocrine Disorders; Lambadiari V, Kountouri A et. al.

Feb 12th, 2021 - Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies have suggested dipeptidyl-peptidase 4 inhibitors as possible predisposing agents of bullous pemphigoid. The objective of our study was to prospectively e...

see more →

News  63 results

Distinct Violaceous Plaques in Conjunction With Blisters
https://www.mdedge.com/dermatology/article/216651/dermatopathology/distinct-violaceous-plaques-conjunction-blisters?channel=204
Radhika Grandhi, MD, MPH, Christopher G. Bazewicz, MD et. al.

Feb 4th, 2020 - The Diagnosis: Lichen Planus Pemphigoides Lichen planus pemphigoides (LPP) is a rare autoimmune subepithelial blistering disorder with clinical, pathologic, and immunologic features of lichen planus (LP) and bullous pemphigoid (BP). 1 It mainly ari.

Bullous Pemphigoid: Osmosis Study Video
https://www.medscape.com/viewarticle/922005

Dec 19th, 2019 - What is bullous pemphigoid? Bullous pemphigoid is an autoimmune skin disease that causes the skin to form bullae or blisters. This video overview covers key aspects of the causes, symptoms, diagnosis, pathology, and treatment of bullous pemphigoid...

Nicotinamide-containing products gaining interest for aging, dermatologic disorders
https://www.mdedge.com/dermatology/article/206392/aesthetic-dermatology/nicotinamide-containing-products-gaining-interest?channel=39313
Ted Bosworth

Aug 13th, 2019 - NEW YORK – More patients are inquiring about the antiaging claims made for nicotinamide products, according to Christine DeWitt MD, of the department of dermatology, Georgetown University, Washington. She encouraged attendees at the American Acade.

Bullous Systemic Lupus Erythematosus Successfully Treated With Rituximab
https://www.mdedge.com/dermatology/article/202797/autoimmune-diseases/bullous-systemic-lupus-erythematosus-successfully/page/0/1?channel=45

Jun 12th, 2019 - Comment Diagnosis of BSLE Bullous systemic lupus erythematosus is a rare cutaneous complication of SLE. It typically affects young black women in the second to fourth decades of life.

An 84-Year-Old With a Blistering Rash That Is Spreading
https://reference.medscape.com/viewarticle/865301_3

Apr 2nd, 2019 - Which of the following is the most likely diagnosis? Your Peers Chose: Bullous pemphigoid 0% Herpes zoster (shingles) 0% Pemphigus vulgaris 0% Fixed drug eruption 0% Bullous impetigo 0% Discussion The patient in this case exhibited many factors su...

see more →

Patient Education  11 results see all →